ECHELONAesthetics Institute Inc
Echelon collection / 09

CJC-1295 / Ipamorelin

6 mg / 12 mg
Peptide blends
Product profile

CJC-1295 / Ipamorelin

The supplied blend sheet pairs CJC-1295 and Ipamorelin, placing them in the context of growth hormone signaling research. The combination is a distinct catalog item.

Composition & presentation

CJC-1295 6 mg + Ipamorelin 12 mg, as stated on the sheet.

At a glance
IdentityCJC-1295 / Ipamorelin
CategoryPeptide blends
Presentation6 mg / 12 mg
AvailabilityNot confirmed by the supplied specification

What to understand

The source does not identify whether CJC-1295 has DAC or confirm a container volume in its heading. Those details should not be inferred from the product name.

Listed content and concentrations identify a presentation. They are not a dose, treatment plan or indication of clinical suitability.

Detailed specification tables

Presentation
Stated total content6 mg / 12 mg
Stated container volumeNot confirmed
Label concentrationNot confirmed
Components stated in the supplied sheet
CJC-12956 mg
Ipamorelin12 mg

Concentration values are reconciled with the stated total and volume. They are composition details, not a dose or syringe-unit guide.

Topics discussed in the supplied information

The supplied sheet discusses the areas below. They describe the source material’s research or promotional focus and are not verified therapeutic outcomes for this exact preparation.

Source-described areas
Growth hormone signalingThe source discusses growth hormone and IGF-1 signaling.
Other stated topicsBody composition, recovery and sleep are areas discussed by the sheet.
Send Inquiry

Ask our team about this product and presentation.

Read the companion article

Why each component needs its own specification. Explore this entry’s identity, how to read its specifications and what documentation to check.

Read the full article